GATC Health
The AI engine Fit Assessment
BetaGATC Health effectively leverages machine learning to discover health patterns and expand therapeutics, while also utilizing its platform for potential drug repurposing.
Blurb
GATC Health uses AI to speed drug discovery, predict outcomes, and support research with data-driven healthcare insights.
HQ Location
Irvine (United States)
Founded
2020
Employees
11 - 50
Total funding raised
$5.41M
Last Funding Event
Seed, $240.00K, August 23, 2023
Smart insights
- Catherine Msc (Chief People Officer) worked at Lilium as Head of People Business Partnering for 1.5 years (2021 - 2022)
- Val Miftakhov (Founder & CEO) worked at Google in various roles, including Head of R&D, Google for Work Incubation, for a total of 4 years (2012 - 2016)
- 6m headcount growth: 25%
- 1Y headcount growth: 94%
- Headcount-to-last-round ratio: 5.3 employees/$M
Subspaces
- Drug Repurposing
GATC Health develops the Multiomics Advanced Technology platform to accelerate drug discovery and healthcare research. The platform uses neural networks and machine learning to simulate human physiology, predict drug efficacy and safety, and generate new drug candidates. It supports pharmaceutical companies, labs, universities, health providers, and government organizations with predictive analytics and optimized clinical trial processes.